Methacrylate-Modified Corneal Endothelial Sheet Adhesion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current corneal endothelial surgeries face challenges such as corneal implant detachment and excessive loss of endothelium due to inadequate adhesion of artificial corneal endothelial sheets, requiring high-quality donor corneas and multiple surgical procedures.
Innovation Solution
A modified artificial corneal endothelial sheet with an adhesion-increase treatment involving a methacrylate-modified polyamino polymer, achieved through an epoxy-amine ring-opening reaction and photo-initiated free radical polymerization, enhancing the sheet's adhesion to the posterior corneal matrix.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional artificial corneal endothelial sheets are used, then surgical procedures can be performed, but the adhesion is insufficient leading to postoperative detachment
Solution Approach 1:
The patent applies parameter changes by modifying the surface chemistry of the artificial corneal endothelial sheet through methacrylate functionalization. This chemical modification changes the surface parameters to enable covalent bonding with the posterior corneal matrix, thereby improving adhesion strength without fundamentally altering the manufacturing process complexity
Solution Approach 2:
The patent uses composite materials by combining the artificial corneal endothelial sheet with methacrylate functional groups. This creates a composite structure where the base material provides the endothelial function while the methacrylate layer provides enhanced adhesion through photo-initiated polymerization, resolving the contradiction between adhesion strength and manufacturing complexity
2Reliability
If high-quality donor corneas are used for endothelial keratoplasty, then surgical success improves, but donor availability and cost increase
Solution Approach 1:
The patent employs disposable artificial corneal endothelial sheets with adhesion-increase treatment instead of requiring high-quality donor corneas. These artificial sheets can be mass-produced at lower cost and are designed for single-use implantation, thereby improving surgical success rates while increasing availability by eliminating the need for scarce donor tissues
Solution Approach 2:
The patent creates an artificial copy of the corneal endothelial layer with enhanced adhesion properties. This artificial copy replicates the essential function of the natural endothelium while incorporating methacrylate functional groups for improved bonding, allowing widespread use without depleting donor cornea resources
3Reliability
If adhesion-increase treatment is applied to artificial corneal endothelial sheets, then detachment rates decrease, but treatment process complexity increases
Solution Approach 1:
The patent applies preliminary action by pre-modifying the artificial corneal endothelial sheet with methacrylate functional groups before implantation. This advance preparation ensures that the adhesion capability is built into the device itself, reducing the need for complex intraoperative adhesion-promoting procedures and improving postoperative stability
Solution Approach 2:
The patent replaces mechanical adhesion methods with chemical bonding through photo-initiated free radical polymerization. Instead of relying on mechanical interlocking or sutures, the methacrylate-functionalized surface forms covalent bonds with the posterior corneal matrix, simplifying the overall treatment process while enhancing reliability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The treated sheets demonstrate strong adhesion, reduced detachment rates, and improved biocompatibility, allowing for smaller incisions and fewer complications, potentially replacing traditional donor grafts and reducing the need for multiple transplants.
Implementation Method 1
an adhesion-increase treatment includes obtaining a methacrylate modified polyamino polymer by an epoxy-amine ring-opening reaction of polyamino high-molecular polymer and glycidyl methacrylate
Implementation Method 2
performing surface modification of the artificial corneal endothelial sheet by photo-initiated free radical polymerization reaction
Data Source
AI summary
A corneal implant with adhesion-increase treatment is associated with a method for increasing the adhesion of the artificial corneal implant by an epoxy-amine ring-opening reaction of the polyamino high-molecular polymer and glycidyl methacrylate to obtain a methacrylate modified polyamino polymer. The method improves the adhesion and biocompatibility of the artificial corneal endothelial sheet by photo-initiated free radical polymerization reaction, and has a high oxygen permeability and a high adhesion. It can be used for treating patients with corneal endothelial decompensation, playing a barrier role to block aqueous humor, eliminating corneal edema, and reducing the risk of corneal graft detachment after surgery.